Research Grade Bebtelovimab (MO-NAB-002F)


Cat: MO-NAB-002F
Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number

  • Product Details

Specifications

Host speciesHuman
Species ReactivitySARS-CoV-2
SpecificityRecognize Receptor-Binding Domain, RBD, Spike glycoprotein, S glycoprotein, E2, Peplomer protein, Spike protein S1, S. Neutralizing antigen from Wuhan to Omicron.
ImmunogenRecombinant SARS-CoV-2 RBD protein
FormatLiquid
BufferPBS, pH7.5
Regulatory StatusFor Research Use Only. Not For Clinical Use.
ShippingGel Pack
StorageStore at 2 to 8°C for one week.
From the date of receipt, store at -20 to -80 °C for 12 months. Avoid repeated freeze-thaw cycles.
Purity> 95% was determined by SDS-PAGE
PurificationProtein A or G purified

Application Information

ApplicationNeut
Application NotesThe optimal dilution should be determined by the end user.

Target

IntroductionSARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2), also known as 2019-nCoV (2019 Novel Coronavirus), is a virus that can cause serious illnesses from the common cold. SARS-CoV-2 Spike protein consists of S1 domain and S2 domain. S1 contains a receptor binding domain (RBD) that specifically binds to the receptor angiotensin converting enzyme 2 (ACE2) on target cells. It is believed that the SARS-CoV-2 spike protein (RBD) has potential value for the diagnosis of the virus.
Alternative NamesLY-CoV1404, LY3853113
UniProt IDP0DTC2
For Research Use Only | Not For Clinical Use.

Online Inquiry